Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.

Keeling SO, Alabdurubalnabi Z, Avina-Zubieta A, Barr S, Bergeron L, Bernatsky S, Bourre-Tessier J, Clarke A, Baril-Dionne A, Dutz J, Ensworth S, Fifi-Mah A, Fortin PR, Gladman DD, Haaland D, Hanly JG, Hiraki LT, Hussein S, Legault K, Levy D, Lim L, Matsos M, McDonald EG, Medina-Rosas J, Pardo Pardi J, Peschken C, Pineau C, Pope J, Rader T, Reynolds J, Silverman E, Tselios K, Suitner M, Urowitz M, Touma Z, Vinet E, Santesso N.

J Rheumatol. 2018 Oct;45(10):1426-1439. doi: 10.3899/jrheum.171459. Epub 2018 Sep 1.

2.

Measuring Disease Activity and Damage with Validated Metrics: A Systematic Review on Mortality and Damage in Systemic Lupus Erythematosus.

Keeling SO, Vandermeer B, Medina J, Chatterley T, Nevskaya T, Pope J, Alaburubalnabi Z, Bissonauth A, Touma Z.

J Rheumatol. 2018 Oct;45(10):1448-1461. doi: 10.3899/jrheum.171310. Epub 2018 Aug 15.

3.

Subcutaneous belimumab in the treatment of systemic lupus erythematosus.

Elalouf O, Keeling SO, Touma Z.

Immunotherapy. 2018 Sep;10(13):1163-1173. doi: 10.2217/imt-2018-0061. Epub 2018 Aug 14.

PMID:
30105936
4.

Practice Variations in the Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus in Canada.

Keeling SO, Bissonauth A, Bernatsky S, Vandermeer B, Fortin PR, Gladman DD, Peschken C, Urowitz MB.

J Rheumatol. 2018 Oct;45(10):1440-1447. doi: 10.3899/jrheum.171307. Epub 2018 Aug 1.

5.

Clinical effectiveness and safety of leflunomide in inflammatory arthritis: a report from the RAPPORT database with supporting patient survey.

Schultz M, Keeling SO, Katz SJ, Maksymowych WP, Eurich DT, Hall JJ.

Clin Rheumatol. 2017 Jul;36(7):1471-1478. doi: 10.1007/s10067-017-3687-5. Epub 2017 May 27.

PMID:
28550389
6.

Preliminary validation of a self-reported screening questionnaire for inflammatory back pain.

Keeling SO, Majumdar SR, Conner-Spady B, BattiƩ MC, Carroll LJ, Maksymowych WP.

J Rheumatol. 2012 Apr;39(4):822-9. doi: 10.3899/jrheum.110537. Epub 2012 Feb 15.

PMID:
22337237
7.

Lack of cardiovascular risk assessment in inflammatory arthritis and systemic lupus erythematosus patients at a tertiary care center.

Keeling SO, Teo M, Fung D.

Clin Rheumatol. 2011 Oct;30(10):1311-7. doi: 10.1007/s10067-011-1747-9. Epub 2011 Apr 19.

PMID:
21503617
8.

Pregnancy and rheumatic disease: "by the book" or "by the doc".

Keeling SO, Oswald AE.

Clin Rheumatol. 2009 Jan;28(1):1-9. doi: 10.1007/s10067-008-1031-9. Epub 2008 Nov 6. Review.

PMID:
18987777
9.

Testing of the preliminary OMERACT validation criteria for a biomarker to be regarded as reflecting structural damage endpoints in rheumatoid arthritis clinical trials: the example of C-reactive protein.

Keeling SO, Landewe R, van der Heijde D, Bathon J, Boers M, Garnero P, Geusens P, El-Gabalawy H, Inman RD, Kraus VB, Kvien TK, Mease PJ, Ostergaard M, Ritchlin C, Syversen SW, Maksymowych WP.

J Rheumatol. 2007 Mar;34(3):623-33. Review.

PMID:
17343310

Supplemental Content

Loading ...
Support Center